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ABSTRACT 
Evaluation of the effect of hydroalcoholic extracts of Cassia occidentalis leaves in neutrophil adhesion test in Rats. The effect of oral 
administration of hydroalcoholic extract of Cassia occidentalis leaves on neutrophil has been studied and is compared with control group on 
rats. The differential leukocyte count (DLC) was performed by fixing the blood smears and staining with leucofine and percent neutrophils in 
each sample was determined. After the initial counts, blood samples were incubated with 80 mg/ml of nylon fibers for 10 min at 37ºC. 
Supplementation with hydroalcoholic extract of Cassia occidentalis leaves significantly decreased neutrophil adhesion. The results indicate that 
the leaf of Cassia occidentalis is endowed with protected neutrophil adhesion. These effects could conclude that Cassia occidentalis has an 
antiasthmatic property. 
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INTRODUCTION 
Respiratory diseases are second to cancer as the causes of 
death and disability to adults. Acute respiratory infection, 
tuberculosis and chronic obstructive pulmonary disease 
rank third, fourth and fifth respectively as per the global 
health situation.1  
According to a survey in UK in the year 2008, respiratory 
diseases occupied 15% among all other diseases. Asthma is 
the commonest disease in children in economically 
developed countries and it is also common in adults and it is 
increasing in prevalence and severity. Around 275 million 
people around the globe suffer from asthma and this number 
is rising worldwide, deaths from this condition have reached 
18 million annually. The number of deaths from asthma also 
has risen in the United States. The WHO says about five 
thousand Americans die from asthma attacks each year. In 
the early 1980s, the yearly death rate from asthma in the 
United States was about half of that. 
Bronchial asthma is a complex disease with several clinically 
well-defined pathogenic components, including recurrent 
reversible airway obstruction, chronic airway inflammation 
and development of airway hyperresponsiveness.2 Airway 
inflammation is the primary problem in asthma. An initial 
event in asthma appears to be the release of inflammatory 
mediators (e.g., histamine, tryptase, leukotrienes and 
prostaglandins) triggered by exposure to allergens, irritants, 
cold air or exercise. The mediators are released from 
bronchial mast cell, alveolar macrophages, T- lymphocytes 
and epithelial cells. Some mediators directly cause acute 
bronchoconstriction, termed the “early-phase asthmatic 
response”. The inflammatory mediators also direct the 
activation of eosinophils and neutrophils, and their 
migration to the airway, where they cause injury. This is 
called “late-phase asthmatic response” results in epithelial 
damage, airway edema, mucus hypersecretion and 
hyperresponsiveness of bronchial smooth muscle. Varying 
airflow obstruction leads to recurrent episodes of wheezing, 
breathlessness, chest tightness, and cough.3 Based on clinical 
trial grounds and measurement of IgE, there are 2 major 
types of asthma. 1) Extrinsic asthma (atopic asthma) in 
which symptoms develops only on exposure to a specific 
allergen. Extrinsic asthmatics rarely suffer from status 
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asthmatics and require infrequent medication. 2) Intrinsic 
asthma (perennial) in which the symptoms are precipitated 
by infection, frequency of status asthmatics is higher and no 
allergic aetiology is detectable. Both these types behave 
differently to anti asthmatics drugs. Mixed features of both 
the types may be seen in some patients.4 
The gross pathology of asthmatic airway display lung 
hyperinflation, smooth muscle hypertrophy, lamina 
reticularis thickening, mucosal edema, epithelial cell 
sloughing, cilia cell disruption, and mucus gland 
hypersecretion. Microscopically, asthma is characterized by 
presence of increased number of eosinophils, lymphocytes, 
and plasma cells in the bronchial tissues, bronchial 
secretion, and mucus. Initially, there is recruitment of 
leukocytes from the bloodstream to the airway by activated 
CD4 T-lymphocytes also direct the release of inflammatory 
mediators from eosinophils, mast cells, and lymphocytes. In 
addition, the subclass 2-helper T-lymphocytes subset of 
activated T-lymphocytes produces IL-4, IL-5, and IL-13. IL-4 
in conjugation with IL-13 signals the switch from IgM to IgE 
antibodies. The cross linkage of two IgE antibodies 
molecules by allergen causes mast cells to degranulate; 
releasing histamine, leukotrienes, and other mediators that 
perpetuate the airway inflammation. IL-5 activates the 
recruitment and activation of eosinophils. The activated 
mast cells and eosinophils also generate their cytokines that 
help to perpetuate the inflammation. 
Regardless of the triggers of asthma, the repeated cycles of 
inflammation in the lung with injury to the pulmonary 
tissues followed by repair may produce long term structural 
changes (“remodeling”) of the airways.5  
Bronchial asthma is major public health problem worldwide, 
and the morbidity and mortality of asthma have increased in 
past few decades. Between 100-150 million people around 
the global roughly the equivalent of the population of the 
Russian Federation suffers from asthma and this numbers is 
rising. Worldwide, death from this condition have reached 
over 1, 80,000 annually. India has estimated 15-20 million 
asthmatics. In India, rough estimates indicate a prevalence of 
between 10-15% in 5-11 years old children.6 The health 
burden of asthma is increasing globally at an alarming rate, 
providing a strong impetus for the development of new 
therapeutics. 
The world health organization (WHO) has recognized herbal 
medicine as an essential building block for primary health 
care of vast countries like India and China. India is perhaps 
the largest producer of medicinal herbs and is rightly called 
the “botanical garden of the world”. There are very few 
medicinal herbs of commercial importance, which are not 
collected or cultivated in this country. Medicinal herbs have 
been in use for thousands of years, in one form or another, 
under the indigenous system of medicine like Ayurveda, 
Siddha, and Unani. Since independence in 1947, India has 
made tremendous progress in agro technology, process 
technology, standardization, quality control, research and 
development. Large numbers of herbs are being used for the 
treatment and prophylaxis of asthma since ancient time, 
however systemic studies that identify all possible 
mechanism of each and every herbal antiasthmatic drug are 
lacking. 
Asthma is a disease characterized by redcurrant of 
reversible airway obstruction with attack of wheeze, 
shortness of breath and often nocturnal cough. Essential 
features of asthma are airway inflammation which causes 
bronchial hyper responsiveness which in turn results in 
recurrent reversible airway obstruction. There are various 
causative factors for asthma like allergens, drugs induced 
asthma, cold air, irritant chemicals etc. 
Various allopathic drugs like corticosteroids, 
anticholinergics, mast cell stabilizers leukotriene 
antagonists, β2 receptor agonist etc., are in use for the 
treatment for asthma. In the most extents, these drugs have 
been helpful in the symptomatic relief, treatment and 
prophylaxis of asthma. But the involvement of debilitating 
side effects is major drawback of these drugs. For example, 
long-term treatment with corticosteroids leads osteoporosis, 
skeletal muscle myopathy, obesity etc.7  
As a result of problems in asthma, there is high prevalence of 
usage of alternative traditional of medicines for the 
treatment of asthma. Ayurveda offers a unique insight into 
comprehensive approach to asthma management through 
proper care of respiratory tract. More than 400 medicinal 
plant species have been used ethnologically and traditionally 
to treat the symptoms of asthmatics, other allergic and 
autoimmune disorders worldwide. The world health 
organization (WHO) has recognized herbal medicine as an 
essential building block for primary health care of vast 
countries like India and China. India is perhaps the largest 
producer of medicinal herbs and is rightly called the 
“botanical garden of the world”. There are very few 
medicinal herbs of commercial importance, which are not 
collected or cultivated in this country. Medicinal herbs have 
been in use for thousands of years, in one form or another, 
under the indigenous system of medicine like Ayurveda, 
Siddha, and Unani. Since independence in 1947, India has 
made tremendous progress in agro technology, process 
technology, standardization, quality control, research and 
development. Large numbers of herbs are being used for the 
treatment and prophylaxis of asthma since ancient time, 
however systemic studies that identify all possible 
mechanism of each and every herbal antiasthmatic drug are 
lacking. So many herbal drugs are used in treatment of 
bronchospasm. Mostly used herbal drugs are Curcuma longa, 
C. gigantia, Indigofera tinctoria, Asystasia gangetica, Bryonia 
laciniosa etc. Options available today have many limitations 
including risk of adverse effects, where as herbal world 
offers many options with safety, efficacy & availability with 
economical aspects also. Cassia occidentalis, commonly 
known as “Kasundri”, is one of the leading drugs used as 
alternative system of treatments. As per traditional method, 
it is known for its expectorant activity. 
In light of this, the objective of the study is to evaluate the 
effect of hydroalcoholic extracts of Cassia occidentalis in 
neutrophil adhesion test. 
MATERIALS AND METHODOLOGY 
Preparation of extract: 
Leaves of Cassia occidentalis were collected and properly 
cleaned and dried under shade to remove excess of 
moisture. The dried plant material was then subjected to 
size reduction to coarse powder and passed the powder 
from sieve no. 40. About 500 gm of air dried powder of 
leaves of Cassia occidentalis were extracted in soxhlet with 
20:80 ethanols:water hydroalcoholic mixture in soxhlet 
apparatus by continuous hot extraction. After each 
extraction, the solvent was recovered using distillation 
assembly, and the both extracts were concentrated. The 
extracts were preserved in air tied container for experiment.  
Animal selection: 
Healthy adult Albino Wistar rats of either sex were used for 
this study. They were housed at ambient temperature 
(22±1°C), relative humidity (55±5%) and 12h/12h light 
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dark cycle. Animals had free access to standard pellet diet 
and water given ad libitum. The protocol of the experiment 
was approved by the Institutional Animal Ethical Committee 
(IAEC) as per the guidance of the Committee for the Purpose 
of Control and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Social Justice and Empowerment, 
Government of India. 
Neutrophil adhesion test8-9  
The study was carried out as described by Wilkinson PC & 
Ghule BV et al. Albino wistar rats of either sex were used for 
the study. The animals were randomly divided in three 
groups (n =6) and treated accordingly. Duration of 
treatment was 14 days.  
Group I: Control (treated with vehicle, p.o.)  
Group II: Hydroalcoholic extract of C. occidentalis leaf 
(HECL) (100 mg/kg, p.o.) 
Group III: Hydroalcoholic extract of C. occidentalis leaf 
(HECL) (200 mg/kg, p.o.)  
On day 14, blood samples were collected from the retro 
orbital plexus into heparinized vials and analyzed for total 
leukocyte count (TLC). The differential leukocyte count 
(DLC) was performed by fixing the blood smears and 
staining with leucofine and percent neutrophils in each 
sample was determined. After the initial counts, blood 
samples were incubated with 80 mg/ml of nylon fibers for 
10 min at 37ºC. The incubated blood samples were again 
analyzed for TLC and DLC. The product of TLC and percent 
neutrophils gave the neutrophil index of blood sample.  
% neutrophil adhesion was calculated from the following 
formula:  
 
Where, NIu= Neutrophil index of untreated blood sample 
NIt= Neutrophil index of treated blood sample 
Statistical analysis: 
Results were expressed as mean ± SEM. Differences among 
data were determined using one-way ANOVA followed by 
Student–Newman–Keul’s test (Graphpad Prism software for 
Windows, Version 4.10.1998). Differences between the data 
were considered significant at P < 0.05. 
RESULTS AND DISCUSSIONS 
Mucosal inflammation is associated with an increase in the 
expression of vascular and leucocyte adhesion molecules.10-
11 A number of cellular adhesion molecules are involved in 
the adhesion of neutrophils to the site of tissue 
inflammation. Neutrophils must adhere to the endothelium 
and subsequently migrate through the vessels before 
entering the tissue. Neutrophil rolling and arrest on 
endothelium is mediated through successive interactions of 
selectins and β-integrins.12 Neutrophil adhesion to 
endothelium is enhanced by activation of adenosine 
Acompartments.13 Subsequent adhesion to apical epithelial 
membranes results in activated neutrophils persisting in 
crypt abscesses with local release of chemotactic and 
chemoactivating substances.14-15 In addition to producing a 
number of functionally diverse substances, poly-
morphonuclear cells also express receptors for a number of 
mediators including IL-8, IL-9 and the high-affinity IgE 
receptor.16-17 These receptors have been implicated in 
different inflammatory reactions, including allergic asthma. 
Neutrophil recruitment from the circulation into the 
interstitium during inflammation is an extension of a 
physiological process across an adapted, permissive cell 
layer. Such transmigration involves the tethering, rolling, 
tight adhesion, and diapedesis of marginalised flowing 
cells.18 Neutrophil adhesion to the vascular endothelium as 
described in the 'traffic signal' paradigm, results from the 
sequential recruitment of selectins, β
221 
receptors. Binding to 
the adenosine A
2 
receptor results in inhibition of the 
respiratory burst reaction and decreased binding to 
fibrinogen.19-22 The percentage of neutrophil adhesion was 
estimated on day 14. Pretreatment with HECL at dose 100 
and 200 mg/kg, p.o. induced a significant (p < 0.001) 
decrease in the in vitro neutrophil adhesion to nylon fibers 
with respect to that of control group, which correlated the 
decrease in percentage of neutrophils. However, HECL at 
dose of 100 mg/kg did not show any significant change in 
neutrophil adhesion when compared with respective control 
group. Thus hydroalcoholic extract of leaves of Cassia 
occidentalis Linn. reduced significantly percentage of 
neutrophil adhesion. This may help in decreasing the release 
of various cytokines and might be binding to A1
 
and/or A2
 
receptor on endothelium and results in producing anti-
inflammatory action. (Table 1, Figure 1) 
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Figure 1: Effect of hydroalcoholic extract of Cassia 
occidentalis leaves on Neutrophil adhesion test in rats 
 
Table 1 Effect of hydroalcoholic extract of Cassia occidentalis leaves on Neutrophil adhesion test 
Group 
Dose 
(mg/kg) 
Neutrophil Index Neutrophil adhesion 
(%) Untreated blood Fiber treated blood 
Control - 334017 ± 20021 202343 ± 15303 39.71 ± 1.01 
HECL 100 640034 ± 24571 403944 ± 14655 36.85 ± 0.58 
HECL 200 432946 ± 18191 322892 ± 12555 25.37 ± 0.57*** 
Values are Mean ± SEM (n = 6); analyzed by one way ANOVA followed by Turkey’s multiple comparison test, *** p < 0.001 for 
change difference Vs control group. 
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CONCLUSION 
In conclusion, the presented data indicate that 
administration of the hydroalcoholic extract of Cassia 
occidentalis leaves to rats reduced the neutrophil aadhesion, 
supporting folk information regarding antiasthmatic activity 
of the plant. The mechanism underlying this effect is still 
unknown, but is apparently related to reduction in 
neutrophil adhesion. These effects could conclude that Cassia 
occidentalis has an antiasthmatic property.  
REFERENCES 
1. http://google/WHO, 1998. 
2. Kay AB. Asthma and inflammation. J Allergy Clin immunol. 1991; 
87: 893-910. 
3. Bethesda. NHLBI: National Asthma Education and Prevention 
Program, Expert Panel report 2, Guidelines for the diagnosis and 
management of Asthma. NIH Publication. 1997; 97: 4051. 
4. Barar FSK. Drugs acting on respiratory system. In: Essentials of 
Pharmacotherapeutics. 3rd edition. 2003; 544-552. 
5. Fireman P. Understanding asthma Pathophysiology. Allergy 
Asthma Proc. 2003; 24 (2): 79-83. 
6. http:// www.google/ WHO fact sheet, 2000. 
7. Walker R, Edwards C. Clinical pharmacy and therapeutics. 2nd 
edition. 1999: 351-365. 
8. Wilkinson PC. Neutrophil adhesion test. In: Vane JK, Ferreria SH 
(Eds.), Handbook of Experimental Pharmacology, first ed. 
Springer Verlag, Berlin. 1978: 109. 
9. Ghule BV, Murugananthan G, Nakhat PD, Yeole PG. 
Immunostimulant effects of Capparis zeylanica Linn. leaves. 
Journal of Ethnopharmacology. 2006; 108: 311-315. 
10. Balsitis M, Morrell K, Mahida Y, Hawkey CJ. Cell adhesion 
molecule expression by colonic mucosa in ulcerative colitis. Eur J 
Gastroenterol Hepatol. 1994; 6: 351-358. 
11. Dippold W, Wittig B, Schwaeble W, Mayet W, Buschenfelde M. 
Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) 
in colonic epithelial cells. Gut. 1993; 34: 1593-1597. 
12. Susan CF, Qutayba H. Images in allergy and immunology: 
neutrophils in asthma. Journal of Allergy and Clinical 
Immunology. 2007; 119: 1282-1286. 
13. Madara JL. Migration of neutrophils through epithelial 
monolayers. Trends in Cell Biology. 1994; 4: 4-7. 
14. Nathan CF. Neutrophil activation on biological surfaces: massive 
secretion of hydrogen peroxide in response to products of 
macrophages and lymphocytes. J Clin Invest. 1987; 80, 1550-
1560. 
15. Opal SM, Palardy JE, Marra MN, Fisher CJ, McKelligon BM, Scott 
RW. Relative concentrations of endotoxin binding proteins in 
body fluids during infection. Lancet. 1994; 344: 429-431. 
16. Soussi-Gounni A, Koussih L, Nutku E, Lamkhioued B, Nicolaides 
NC, Levitt RC. Functional expression of IL-9 receptor by human 
neutrophils from asthmatic donors: role in IL-8 release. Journal 
of Immunology. 2001; 166: 2768-2774.  
17. Soussi-Gounni A, Lamkhioued B, Koussih L, Ra C, Renzi PM, 
Hamid Q. Human neutrophils express the high-affinity receptor 
for immunoglobulin E (Fc epsilon RI): role in asthma. FASEB J. 
2001; 15: 940-949. 
18. Adams DH, Shaw S. Leucocyte-endothelial interactions and 
regulation of leucocyte migration. Lancet. 1994; 343: 831-836. 
19. Prescott SM, Zimmerman GA, McIntyre TM. Platelet activating 
factor. J Biol Chem. 1982; 1990 (17): 381-384. 
20. Dianzani C, Brunelleschi S, Viano I, Fantozzi R. Adenosine 
modulation of primed human neutrophils. European Journal of 
Pharmacology. 1994; 263: 223-226. 
21. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, 
Weissman G. Neutrophil adherence to endothelium is enhanced 
via adenosine A
l 
receptors and inhibited via adenosine A
2 
receptors. Journal of Immunology. 1992; 148: 2201-2206. 
22. Meenan J, Mevissen M, Monajemi H, Radema SA, Soule HR, Moyle 
M, Tytgat GNJ, van Deventer SJH. Mechanisms underlying 
neutrophil adhesion to apical epithelial membranes. Gut. 1996; 
38: 201-205. 
 
 
 
 
 
 
 
